pharmacokinetics research of mycophenolic acid

Influence of UGT1A9 and UGT2B7 polymorphisms on the mycophenolic acid pharmacokinetics

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-10000805

Enrollment

Unknown

Registered

2010-03-08

Start date

2008-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

1:non mutated

2:homozygotes of UGT1A9*1b

3:heterozygotes of UGT1A9

4:homozygotes and heterozygotes of UGT2B7

Eligibility

Sex/Gender

Male

Age

19 Years to 23 Years

Inclusion criteria

Inclusion criteria: healthy volunteers (normal physical examination and liver and renal function) with proper genotype

Exclusion criteria

Exclusion criteria: without proper genotype and extremely higher or lower albumin concentration

Design outcomes

Primary

Measure	Time frame
plasma concentration;	—

Countries

China

Contacts

Public ContactDong Guo

csugd@126.com+86 0731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026